Quality Control for Flexible Sigmoidoscopy: Which Polyps Count?

Gastroenterology

Volumn 126, Issue 5, 2004, Pages 1474-1477

  Zauber, Ann G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM; CYCLOOXYGENASE 2 INHIBITOR; FOLIC ACID; MULTIVITAMIN; NONSTEROID ANTIINFLAMMATORY AGENT;

AGE DISTRIBUTION; CAUSE OF DEATH; COLORECTAL CANCER; EDITORIAL; FAMILY HISTORY; FLEXIBLE SIGMOIDOSCOPY; GENDER; GEOGRAPHIC DISTRIBUTION; HORMONE SUBSTITUTION; HUMAN; POLYP; PRIORITY JOURNAL; QUALITY CONTROL; SIDE EFFECT; SIGMOIDOSCOPY; SMOKING; TRAINING; UNITED STATES;

EID: 2142715389     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.03.029     Document Type: Editorial

References (37)

1. Winswer SJ, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D, Kirk L, Litin S, Simmang C, for the U.S. Multisociety Task Force on Colorectal Cancer Screening. Colorectal cancer screening and surveillance: clinical guidelines and rationale - update based on new evidence. Gastroenterology 2003;124:544-560.
2. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman L, Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-1371.
3. Hardcastle JD, Chamberlain J, Robinson M, Moss S, Amar S, Balfour TW, James PD, Mangham CM. Randomised controlled trial of faecal-occult blood screening for colorectal cancer. Lancet 1996;348:1472-1477.
4. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal occult blood test. Lancet 1996;348:1467-1471.
5. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF, Ackroyd F, Shike M, Kurtz RC, Hornsby-Lewis L, Gerdes H, Stewart ET, and the National Polyp Study Workgroup. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329: 1977-1981.
6. Citrada F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 2001;48:812-815.
7. Smith RA, von Eschenbach AC, Wender R, Levin B, Byers T, Rothenberger D, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001-testing for early lung cancer detection. CA Cancer J Clin 2001;51:38-75.
8. U.S. Preventive Services Task Force. Screening for colorectal cancer: recommendations and rationale. Ann Intern Med 2002; 137:129-131.
9. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:132-141.
10. Atkin W, Rogers P, Cardwell C, Cook C, Cuzick J, Wardle J, Edwards R. Wide variation in adenoma detection rates at screening flexible sigmoidoscopy. Gastroenterology 2004;126:1247-1256.
11. UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomized trial. Lancet 2002;359:1291-1300.
12. Atkin W, Edwards R, Wardle J, Northover J, Sutton S, Hart A, Williams C, Cuzick J. Design of a multicentre randomized trial to evaluate flexible sigmoidoscopy in colorectal cancer screening. J Med Screen 2001;8:137-144.
13. Hofstad B, Almendingen K, Vatn M, Andersen SN, Owen RW, Larsen S, et al. Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants. Digestion 1998;59:148-156.
14. O'Brien MJ, Winawer SJ, Zauber AG, Gottlieb LS, Sternberg SS, Diaz B, Dickersin GR, Ewing S, Geller S, Kasimian D, Komorowski R, Szporn A. The National Polyp Study: patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 1990;98:371-379.
15. Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992;326:658-662.
16. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med 2000;343:162-168.
17. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DR. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000;343:169-174.
18. Levin TR, Palitz A, Grossman S, Conell C, Finkler L, Ackerson L, Rumore G, Selby JV. Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy. JAMA 1999;281:1611-1617.
19. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer. Ann Intern Med 2003;139:959-965.
20. Winawer SJ. Screening sigmoidoscopy: can the road to colonoscopy be less traveled? Ann Intern Med 2003;139:1034-1035.
21. Rex DK, Bond JH, Winawer S, Levin TR, Burt RW, Johnson DA, Kirk LM, Litlin S, Lieberman DA, Waye JD, Marshall JB, Riddell RH. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the US multi-society task force on colorectal cancer. Am J Gastroenterol 2002;97:1296-1308.
22. Hixson U, Fannerty MB, Sampliner RE, McGee D, Garewal H. Prospective study of the frequency and size distribution of polyps missed by colonoscopy. J Natl Cancer Inst 1990;82: 1769-1772.
23. Rex DK, Cutler CS, Lemmel GT, Rahmani EY, Clark DW, Helper DJ, Lehman GA, Mark DG. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997; 112:24-28.
24. Winawer SJ, Zauber AG, O'Brien MJ, Ho MN, Gottlieb L, Sternberg SS, Waye JD, Bond J, Schapiro M, Stewart ET, Panish J, Ackroyd F, Kurtz RC, Shike M. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med 1993;328:901-906.
25. Winawer SJ, Zauber AG. The advanced adenoma as the primary target of screening. Gastrointest Endosc Clin North Am 2002;12: 1-9.
26. Harvard Report on Cancer Prevention. Prevention of colon cancer in the United States. Cancer Causes Control 1999;3:167-180.
27. Giovannucci E. An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2001;10:725-731.
28. Burt RW. Colon cancer screening. Gastroenterology 2000;119: 837-853.
29. Winawer SJ, Zauber AG, Gerdes H, O'Brien MJ, Gottlieb L, Stemberg SS, Bond JH, Waye JD, Schapiro M, Panish JF, Kurtz RC, Shike M, Ackroyd FW, Stewart ET, Skolnick M, Bishop DT, and the National Polyp Study Workshop. Risk of colorectal cancer in the families of patients with adenomatous polyps. N Engl J Med 1996;334:82-87.
30. Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, McKeown-Eyssen G, Summers RW, Rothstein R, Burke CA, Snover DC, Church TR, Allen JI, Beach M, Beck GJ, Bond JH, Byers T, Greenberg ER, Mandel JS, Marcon N, Mott LA, Pearson L, Saibil F, van Stolk RU. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003;34:891-899.
31. Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R, Petrelli N, Pipas JM, Karp DD, Loprinzi CL, Steinbach G, Schilsky R. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003;348:883-890.
32. DuBois RN. Will an aspirin a day keep the endoscope away? Gastroenterology 2003;125:612-614.
33. Bertagnolli MM. The potential of non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention. J Surg Oncol 2003;84:113-119.
34. Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Rothstein R, Summers RW, Snover DC, Beck GJ, Bond JH, Greenberg ER. Calcium supplements for the prevention of colorectal adenomas. N Engl J Med 1999;340:101-107.
35. Morrison A. Screening in Chronic Disease. (2nd ed). New York, NY: Oxford, 1992.
36. Brown ML, Klabunde CN, Mysliwiec P. Current capacity for endoscopic colorectal cancer screening in the United States: data from the National Cancer Institute survey of colorectal cancer screening practices. Am J Med 2003;115:129-133.
37. Levin TR, Palitz AM. Flexible sigmoidoscopy: an important screening option for average-risk individuals. Gastrointest Endosc Clin North Am 2002;12:23-40.